The objective of this study was to investigate the changes of NAA, Cho, Cr and the metabolism ratios of deep white matter of frontal lobe and parietal lobe of those who had suicidality in medication-native with single-episode depression. Eighteen healthy control subjects (10 males and 8 females) and eighteen patients with suicidal depression were recruited from the local area. Conventional MRI and 3D-PRESS MRSI was performed in all subjects. All patients were in a depressive state on the day of MR examination with a HAM-D total score higher than 18. NAA/Cr and Cho/Cr ratios on both sides of the striatum were calculated automatically. Relative concentrations of N-acetylaspartate (NAA), choline (Cho) and creatine (Cr) were estimated from their peak area. The regions of interest (ROI) calculated in each subject included right frontal lobe, left frontal lobe, right parietal lobe and left parietal lobe. The MRSI features of depression and healthy volunteers were high and steep peak of NAA, relatively low peak of Cho and Cr. According to the peaks of NAA, Cho and Cr, no obvious differences were found in the images. The differences between depression group and control group in relative concentrations of NAA, Cho and Cr were not significant (P > 0.05). The same situations were found in the analyzing of NAA/Cho and NAA/Cr ratio. In frontal and partial white matter, there were no significant hemispheric differences in metabolite concentrations and ratios. The result in our study hindered that the metabolisms changes in early stage was not obvious in MRSI. The changes of metabolisms will be potential to evaluate of suicidal depression.
Magnetic resonance imaging Magnetic resonance spectroscopy Suicidality Depression Deep white matter
This is a preview of subscription content, log in to check access.
This study was supported by a grant from Shandong Province Science and Technology Development Plan (2010GSF10226) and Program of Committee of the Youth and Middle-aged Scientific Research Foundation of Shan Dong Province (BS2012YY038).
Caetano SC, Fonseca M, Olvera RL et al (2005) Proton spectroscopy study of the left dorsolateral prefrontal cortex in pediatric depressed patients. Neurosci Lett 384:321–326CrossRefGoogle Scholar
Danielsen EA, Ross B (1999) Magnetic resonance spectroscopy diagnosis of neurological diseases. Marcel Dekker, New YorkGoogle Scholar
Ethofer T, Mader I, Seeger U et al (2003) Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3 Tesla. Magn Reson Med 50:1296–1301CrossRefGoogle Scholar
Fekadu A, Wooderson SC, Markopoulo K et al (2009) What happens to patients with treat-ment-resistant depression? A systematic review of medium to long term outcome studies. J Affect Disord 116:4–11CrossRefGoogle Scholar
First MB, Gibbon M, Spitzer RL (1997) Structured Clinical Interview for DSM-IV Axis I Disorders–Clinical Version (SCID–CV). American Psychiatric Publishing, WashingtonGoogle Scholar
Goelman G, Liu S, Hess D et al (2006) Optimizing the efficiency of high-field multivoxel spectroscopic imaging by multiplexing in space and time. Magn Reson Med 56:34–40CrossRefGoogle Scholar
Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278–296CrossRefGoogle Scholar
Kumar A, Thomas A, Lavretsky H et al (2002) Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. Am J Psychiatry 159:630–636CrossRefGoogle Scholar
Kupfer DJ, Frank E, Phillips ML (2012) Major depressive disorder: new clinical, neurobio-logical, and treatment perspectives. Lancet 379:1045–1055CrossRefGoogle Scholar
Lacerda AL, Nicoletti MA, Brambilla P et al (2003) Anatomical MRI study of basal ganglia in major depressive disorder. Psychiatry Res 124:129–140CrossRefGoogle Scholar
Li BS, Wang H, Gonen O (2003) Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. Magn Reson Imaging 21:923–928CrossRefGoogle Scholar
Loffelholz K, Klein J, Koppen A (1993) Choline, a precursor of acetylcholine and phospholipids in the brain. Prog Brain Res 98:197–200CrossRefGoogle Scholar
Mirza Y, O’Neill J, Smith EA et al (2006) Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obses-sive-compulsive disorder versus major depression and healthy controls. J Child Neurol 21:106–111CrossRefGoogle Scholar
Murata T, Kimura H, Omori M et al (2001) MRI white matter hyper-intensities, (1)H-MR spectroscopy and cognitive function in geriatric depression: a comparison of early- and late-onset cases. Int J Geriatr Psychiatry 16:1129–1135CrossRefGoogle Scholar
Sheehan DV, Lecrubier Y, Sheehan KH et al (1998) The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22–33, quiz 34–57Google Scholar
Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI (2004) Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 67:269–275CrossRefGoogle Scholar
Vythilingam M, Charles HC, Tupler LA et al (2003) Focal and lateralized subcortical abnor-malities in unipolar major depressive disorder: an automated multivoxel proton magnetic resonance spectroscopy study. Biol Psychiatry 54:744–750CrossRefGoogle Scholar
Wong ML, Licinio J (2001) Research and treatment approaches to depression. Nat Rev Neurosci 2:343–351CrossRefGoogle Scholar